Actively Recruiting
Evaluating Sonlicromanols Effects on Fatigue and Physical Function in Adults With Mitochondrial DNA tRNALeuUUR m.3243A>G Mutation A Randomized, Double-Blind, Placebo-Controlled Trial
Led by Khondrion BV · Updated on 2026-10-14
220
Participants Needed
10
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the medicine sonlicromanol to see if it can reduce fatigue symptoms and lessen the impact of fatigue on daily life in people with mitochondrial disease. The study also investigates whether sonlicromanol improves physical abilities such as balance control and lower limb muscle strength. This Phase III study compares sonlicromanol with a placebo and assesses its effects on primary, secondary, and exploratory outcomes, as well as safety and tolerability over one year. Participants are randomly assigned to receive either sonlicromanol tablets 90 mg twice daily or matching placebo tablets twice daily for 52 weeks. The study is double-blind, meaning neither participants nor researchers know who receives the active medicine or placebo. The screening period lasts up to 4 weeks to confirm eligibility, and after completing treatment, a follow-up visit occurs 2 weeks after the last dose. Total participation lasts about 60 weeks. During the study, participants undergo regular assessments including fatigue questionnaires Neuro-QoL Fatigue Short Form, physical tests like the Five Times Sit-To-Stand Test, and other surveys to evaluate quality of life, fatigue, depression, and global impressions of severity. These assessments occur at screening, baseline, and every 13 weeks through Week 52. Safety and tolerability are closely monitored throughout the trial to evaluate the medicines impact and participant well-being.
CONDITIONS
Brief Title
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Research Team
J
Jasper Levink, MSc.
G
G. Ruiterkamp, MSc.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here